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Conclusions: The methods developed in this study are based
on general principles, and showed a significant correlation with
a widely used grading protocol for a urine model of OA. The
usefulness of these methods for other animal models, other
grading protocols, and in treatment studies needs to be further
demonstrated.
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INTERLEUKIN-1 ALPHA IN COMPARISON TO
INTERLEUKIN-1 BETA IS A MORE POTENT STIMULATOR
OF AGGRECANASE MEDIATED AGGRECAN
DEGRADATION IN HUMAN ARTICULAR CARTILAGE
E.U. Sumer, B.-C. Sondergaard, S.H. Madsen, P. Qvist,
M.A. Karsdal
Nordic Bioscience, Herlev, Denmark
Purpose: Aggrecan is the predominant proteoglycan in the ex-
tracellular matrix of articular cartilage. One of the early steps in
initiation of cartilage degradation is loss of proteoglycans, which
leads to further degradation of the collagen network. Interleukin-
1 (IL-1) is a potent pro-inflammatory cytokine associated with
the pathology of osteoarthritis (OA). However, controversy exists
regarding the potency of IL-1alpha (IL-1α) compared to IL-1beta
(IL-1β) on degradation of articular cartilage. Therefore, the aim
of the present work was to assess the potential of IL-1α and
IL-1β on human articular cartilage degradation, through quanti-
fying MMP and aggrecanase activity with special emphasis on
protease generated fragments of aggrecan.
Methods: Articular cartilage was obtained from OA patients un-
dergoing total kne arthroplasty. Articular cartilage explants were
cultured for 21 days with refreshment of medium every 3rd day
in the presence of 100 ng/mL IL-1α or 100 ng/mL IL-1β to stim-
ulate cartilage degradation. As negative control, explants were
cultured without stimulation. Cartilage degradation was moni-
tored by measuring the conditioned medium in 2 independent
sandwich assays (1) 342-G2 assay, composed of the capturing
antibody AF-28 against the 342FFGVG neo-epitope generated by
MMP-cleavage and the monoclonal antibody F-78 binding to both
the Globular 1 (G1) and Globular 2 (G2) domain of aggrecan; (2)
374-G2 assay, made up by the capturing antibody BC-3 against
the 374ARGSVI neo-epitope created by aggrecanase cleavage
and F-78.
Results: Both IL-1α or IL-1β stimulated aggrecanase mediated
cartilage degradation as measured by the 374-G2 assay. How-
ever, IL-1α was approximately 200% more potent in inducing
aggrecanase activity in human chondrocytes compared to IL-1β
at equimolar concentrations. Neither IL-1α or IL-1β treatment
of the human articular cartilage explants resulted in increased
release of MMP generated fragments of aggrecan quantified by
the 342-G2 assay.
Conclusions: Both IL-1α or IL-1β induce aggrecanases in hu-
man osteoarthritic cartilage. However, IL-1α seems to be approx-
imately 200% more potent than IL-1β, suggesting important dif-
ferences in cartilage metabolism induced by these two cytokines.
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ESTROGEN DEFICIENCY RESULTS IN INCREASED TYPE
II COLLAGEN DEGRADATION AND DECREASED
SYNTHESIS, WHICH LEAD TO INCREASED CARTILAGE
EROSION
A.K. Olsen1, B.-C. Sondergaard1, R.H. Nielsen1,
S. Oestergaard1, P. Qvist1, C. Christiansen2, M.A. Karsdal1
1Nordic Bioscience, Herlev, Denmark, 2CCBR, Ballerup, Denmark
Purpose: Cartilage degradation is a hallmark in osteoarthritis
(OA) and loss of estrogen has been shown to be associated
with increased prevalence of OA in postmenopausal women.
We investigated the effect of estrogen on cartilage health in the
ovariectomized (OVX) rat model by measuring collagen type II
degradation and a novel markers of collagen type II formation.
Methods: In vivo, forty 7-month old Sprague-Dawley rats were
divided into four groups. One group was subjected to sham op-
eration, whereas the others to OVX, followed by treatment with
either vehicle alone, 17-β-estradiol [0.25mg/pellet s.c. implanted]
initiated instantly after surgery and continued until termination
after 9 weeks. Serum was collected at baseline and week 4,
6 and 9 (termination), followed by quantification of telopep-
tides from collagen type II degradation(CTX-II) and fragments
of pro-peptides of type II collagen (PIINP) by ELISA. Cartilage
erosion was evaluated by histology through toluidine blue stain-
ing followed by microscopic measurement of the eroded articular
cartilage surfaces of the four condyles.
Results: Cartilage degradation (CTX-II) was significantly ele-
vated after week 2, P<0.001; 200%, and remained higher than
sham operated-rats throughout the nine weeks. In contrast, PI-
INP levels in OVX rats were significantly lower, P<0.05; 50%,
than sham-operated animals at week 6 and 9.
Treatment with estrogen to OVX rats resulted in a suppression of
CTX-II release to below sham-operated animals, P<0.01. With
regards to cartilage formation, estrogen treatment of OVX rats,
restored PIINP levels to sham levels, P<0.01. Histological eval-
uation of cartilage erosions in estrogen deficient (OVX) animals
compared to that of sham operated animals, displayed an 150%
increase in cartilage erosion, P<0.01. This was completely re-
stored to sham levels by estrogen replacement, P<0.01.
Conclusions: Loss of estrogen may result both in an increase
in cartilage degradation and a decrease in cartilage formation.
Consequently loss of estrogen results in increased cartilage ero-
sion. This emphasises the importance of measuring both tissue
formation and degradation when evaluating potential treatment
for OA.
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A LONGITUDINAL ANALYSIS OF SERUM CYTOKINES IN
THE HARTLEY GUINEA PIG MODEL OF
OSTEOARTHRITIS
J.L. Huebner, D.R. Seifer, V.B. Kraus
Duke University Medical Center, Durham, NC
Purpose: To examine the levels of a panel of cytokines in the
serum of Hartley guinea pigs ranging from 3 weeks to 18 months
of age in order to identify biochemical markers of osteoarthritis.
Methods: Forty six male Hartley guinea pigs were obtained from
Charles River Laboratories and sacrificed at time points from
3 weeks to 18 months of age, at which time blood samples
were obtained. Histological severity of knee OA was determined
using a semi-quantitative grading scheme described previously,
which assessed cartilage structure abnormalities and proteogly-
can loss. Cytokines and chemokines in the serum were mea-
sured using the Bio-Plex Protein Array System with the Bio-Plex
Mouse cytokine 18-Plex Panel. Cytokine concentrations were log
transformed to meet assumptions of normalcy. To differentiate
OA-related from purely age-related effects, we evaluated the
association between cytokine serum concentrations (pg/ml) and
total histological score for the cytokines that previously showed
a significant difference between age-matched animals differing
in OA susceptibility, namely the OA-prone Hartley strain and
the OA-resistant Strain 13. Standard correlation analyses and
multiple linear regression were performed using JMP Discovery
software. Values were considered significant after adjustment for
multiple testing using the Holm method.
Results: Histological OA presented at 4 months and significantly
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worsened through 18 months. Despite the use of a kit designed
for mouse sera, levels above detection limits were obtained for
16 of the 18 cytokines and chemokines measured (IL-1 alpha
and IL-4 were undetectable). Serum concentrations of each of
the measurable cytokines and chemokines displayed a similar
bimodal distribution, with a first peak occurring at 2 months of
age, a nadir at 7 months of age, and a significant increase from
7 to 18 months of age corresponding to the period of histo-
logical OA development in this model system (Fig. 1). Of the
11 cytokines associated with OA susceptibility in age-matched
animals of two different strains, 7 showed a positive association
with total histological severity: IL-6 (p=0.016), G-CSF (p=0.024),
IL-2 (p=0.032), IL-12p70 (p=0.036), IL-5 (p=0.042), GM-CSF
(p=0.044), and IL-17 (p=0.047). None of these were significantly
associated with animal weight. After correcting for multiple com-
parisons, two correlations remained significant (IL-6 and G-CSF)
and were evaluated further with multiple linear regression. The
two resultant models, IL-6 and weight, and G-CSF and weight,
explained 43-44% of the variance in total histological score re-
spectively, with the cytokine and weight presenting significant
p-values in both models. Utilizing the serum concentrations of
both of these cytokines did not improve upon the predictive ability
of the model.
Conclusions: The association of IL-6 and G-CSF with histologi-
cal OA is independent of weight. Though the observed changes
of these cytokine levels may be due to a correlation with age,
it is unlikely given their pattern of age-related bimodal variance
and the significant difference between Hartley and Strain 13
age-matched cohorts. IL-6 has been shown to play a role in
inflammatory arthritis and synovial fluid levels are associated
with synovitis and cartilage degeneration. G-CSF can induce
changes in the production of inflammatory mediators such nitric
oxide and PGE2 from cartilage chondrocytes and may therefore
play a role in influencing cartilage metabolism in rheumatoid and
osteoarthritis. These results warrant further investigation of these
cytokines in the context of human OA.
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EVALUATION OF JOINT PATHOLOGY BY MEASURING
CARTILAGE DEGRADATION PRODUCTS IN JOINT
EXTRACTS
R.H. Nielsen1, R. Stoop2, D.J. Leeming1, B.-C. Sondergaard1,
A.K. Olsen1, E.U. Sumer1, P. Qvist1, C. Christiansen3,
M.A. Karsdal1
1Nordic Bioscience A/S, Herlev, Denmark, 2Tübingen University,
Reutlingen, Germany, 3CCBR, Ballerup, Denmark
Purpose: One model of Osteoarthritis (OA) is the anterior cru-
ciate ligament transection (ACLT) model in rats. Protease degra-
dation of collagens and proteoglycans in the articular cartilage is
an integrated part in the development of OA, which most often
is evaluated by histology through various staining techniques.
We investigated whether simple extraction of proteins from knee
joints could be a measurement of joint pathology. Thus, instead of
only performing traditional histology, we investigated whether col-
lagen type II degradation measured by specific ELISA technique,
could be used as surrogated assessment for joint pathology, and
thereby be a novel method of evaluating the entire pathology
status of joints.
Methods: Twentyfour female Wistar rats (150-175g) were ran-
domized into 3 groups and surgical OA was induced by ACLT in
one knee joint, while the contralateral knee was sham operated.
Urine and serum was collected at baseline and on day 7, 14,
21 and 28 after surgery. Groups of rats (n=8) were terminated
7, 14 and 28 days after surgery. ACLT- and sham-operated knee
joints were either snap-frozen in liquid nitrogen, homogenized
and extracted for proteins in an extraction buffer, or fixated in
formaldehyde and decalcified in EDTA for histology and immuno-
histochemistry. The extraction buffer contained 50mM TrisHCl
(pH 7.4), 0.1 NaCl, 0.1% Triton X-100 and protease inhibitors.
Levels of C-terminal telopeptides of type II collagen (CTX-II) were
measured in protein extracts from joints. Proteoglycan loss, car-
tilage erosion and osteophyte formation in the chondyle articular
cartilage was evaluated by histology, and immunohistochemistry
for the CTX-II epitope was performed.
Results: The articular cartilage and bone appearence in sham
operated knees appeared histologically normal throughout the
experiment. In ACLT-operated knee joints, degenerative changes
in the surface articular cartilage evaluated by histology and
immunohistochemistry were evident 7 days after surgery and
seen throughout the study period. By extraction of proteins
